Protecting children and older adults from invasive pneumococcal disease

Strategies to increase vaccination rates to reduce morbidity and mortality. A Professor Allan Cripps tribute.

This event highlights Prof. Cripps’ key achievements and sheds light on the advancements in diagnosis, treatment, and prevention of pneumococcal disease.

Our expert panel will discuss pneumococcal disease, vaccine development, and the impact of vaccines on disease reduction in both adults and children. They also will discuss the different serotypes and their effects across age groups, provide insights into invasive pneumococcal disease, immunisation recommendations, and compare polysaccharide and conjugate vaccine types.

The panel will review some valent options and the future pneumococcal immunisation program for reducing disease burden. Additionally, strategies to increase immunisation rates among older adults and high-risk groups will be covered.

Webinar 27 Aug, 4.30 PM – 7.30 PM AWST (6.30 PM – 7.30 PM AEST)

Register now